| 1 | Asphyxiating thoracic dystrophy | Enrichment | DYNC2H1, DYNC2I1, DYNC2I2, EVC2, IFT140, IFT27, IFT74, IFT80, IFT81, TRAF3IP1, TTC21B, WDR19, WDR35 | 11.42 |
| 2 | Retinitis pigmentosa | Enrichment | ARL3, ARL6, BBIP1, BBS1, BBS10, BBS12, BBS2, BBS4, BBS7, BBS9, CEP290, CFAP410, CFAP418, CNGA1, CNGB1, CRX, IFT122, IFT140, IFT172, IFT43, IFT81, INPP5E, IQCB1, LCA5, MAK, MKS1, PCARE, TMEM216, TTC8 | 10.92 |
| 3 | Jeune thoracic dystrophy | Enrichment | DYNC2H1, DYNC2I1, DYNC2I2, EVC2, IFT140, IFT27, IFT74, IFT80, IFT81, TRAF3IP1, TTC21B, WDR19, WDR35 | 10.92 |
| 4 | Isolated joubert syndrome | Enrichment | ARL3, ARMC9, CEP104, IFT74, INPP5E, MKS1, OFD1, TCTN1, TMEM67 | 10.86 |
| 5 | Bardet-biedl syndrome | Enrichment | ARL6, BBIP1, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, CEP290, CFAP418, IFT172, IFT27, IFT74, IQCB1, LZTFL1, MKKS, MKS1, SCLT1, SDCCAG8, TMEM67, TRIM32, TTC8, WDPCP | 10.82 |
| 6 | Joubert syndrome 1 | Enrichment | ARMC9, CC2D2A, CEP104, IFT172, INPP5E, MKS1, OFD1, TCTN1, TMEM67 | 10.78 |
| 7 | Polycystic kidney disease | Enrichment | CEP290, IFT140, MKKS, NPHP3, PKD1, PKD2, PKHD1 | 10.73 |
| 8 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | DYNC2H1, DYNC2I1, DYNC2I2, DYNC2LI1, EVC2, IFT140, IFT172, IFT27, IFT74, IFT80, IFT81, TRAF3IP1, TTC21B, WDR19, WDR35 | 10.71 |
| 9 | Bardet-biedl syndrome 1 | Enrichment | ARL6, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, KIF7, MKKS | 10.70 |
| 10 | Senior-loken syndrome 1 | Enrichment | CEP164, CEP290, INVS, IQCB1, NPHP3, SDCCAG8, TRAF3IP1, TTC21B, WDR19 | 10.70 |
| 11 | Short-rib thoracic dysplasia 6 with or without polydactyly | Enrichment | DYNC2H1, EVC, EVC2, FUZ, IFT172, IFT80, NEK1, TRAF3IP1, TTC21B | 10.69 |
| 12 | Hereditary retinal dystrophy | Enrichment | ARL6, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, CEP164, CEP290, CFAP410, CFAP418, CNGA1, CNGB1, CRX, DYNC2H1, IFT140, IFT172, IFT81, INPP5E, IQCB1, LCA5, MAK, MKKS, PCARE, SDCCAG8, TRIM32, TTC21B, TTC8, WDR19 | 10.58 |
| 13 | Fundus dystrophy | Enrichment | ARL6, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, CEP164, CEP290, CFAP410, CFAP418, CNGA1, CNGB1, CRX, DYNC2H1, IFT140, IFT172, IFT81, INPP5E, IQCB1, LCA5, MAK, MKKS, PCARE, SDCCAG8, TRIM32, TTC21B, TTC8, WDR19 | 10.58 |
| 14 | Short-rib thoracic dysplasia 12 | Enrichment | DYNC2H1, EVC2, IFT122, IFT80, NEK1, TTC21B, WDR19 | 10.56 |
| 15 | Short rib-polydactyly syndrome | Enrichment | DYNC2H1, IFT43, IFT52, IFT81, NEK1, WDR35 | 10.53 |
| 16 | Cranioectodermal dysplasia | Enrichment | CILK1, IFT122, IFT140, IFT43, IFT52, WDR19, WDR35 | 10.50 |
| 17 | Nephronophthisis | Enrichment | CEP290, IFT140, INVS, IQCB1, MKKS, NPHP3, TTC21B, WDR19 | 10.40 |
| 18 | Cranioectodermal dysplasia 1 | Enrichment | CILK1, IFT122, IFT140, WDR19, WDR35 | 10.34 |
| 19 | Short rib-polydactyly syndrome, verma-naumoff type | Enrichment | DYNC2H1, DYNC2I1, DYNC2I2, IFT80, WDR35 | 10.33 |
| 20 | Short-rib thoracic dysplasia 3 with or without polydactyly | Enrichment | BBS10, DYNC2H1, DYNC2I1, DYNC2I2, DYNLT2B, NEK1 | 10.18 |
| 21 | Leber plus disease | Enrichment | BBS1, CEP290, CFAP410, CLUAP1, CRX, IFT140, INPP5E, IQCB1, LCA5, WDR19 | 9.45 |
| 22 | Coach syndrome 1 | Enrichment | CC2D2A, INPP5E, OFD1, TMEM67 | 9.00 |
| 23 | Meckel syndrome, type 1 | Enrichment | CEP290, EVC2, MKS1, TMEM107, TMEM216, TMEM67 | 7.67 |
| 24 | Autosomal dominant polycystic kidney disease | Enrichment | IFT140, NEK8, PKD1, PKD2, PKHD1 | 7.61 |
| 25 | Polycystic kidney disease 4 with or without polycystic liver disease | Enrichment | DYNC2H1, PKD1, PKD2, PKHD1 | 7.01 |
| 26 | Infantile nephronophthisis | Enrichment | INVS, NEK8, NPHP3, TTC21B | 7.01 |
| 27 | Cystic kidney disease | Enrichment | IFT140, PKD1, PKHD1, TMEM67 | 6.75 |
| 28 | Cone-rod dystrophy 2 | Enrichment | CEP290, CFAP410, CFAP418, CNGA1, CRX, IFT81, PCARE | 6.68 |
| 29 | Short-rib thoracic dysplasia 9 with or without polydactyly | Enrichment | IFT140, IFT172, WDR19 | 6.28 |
| 30 | Joubert syndrome with ocular defect | Enrichment | CEP41, INPP5E, MKS1 | 5.63 |
| 31 | Ellis-van creveld syndrome | Enrichment | DYNC2LI1, EVC, EVC2 | 5.36 |
| 32 | Multicystic kidney dysplasia | Enrichment | MKKS, PKD1, PKD2 | 5.33 |
| 33 | Multicystic dysplastic kidney | Enrichment | MKKS, PKD1, PKD2 | 5.33 |
| 34 | Bardet-biedl syndrome 22 | Enrichment | IFT172, IFT74 | 4.84 |
| 35 | Joubert syndrome 10 | Enrichment | CC2D2A, OFD1 | 4.84 |
| 36 | Polydactyly, postaxial, type a1 | Enrichment | BBS12, CC2D2A, IQCE | 4.63 |
| 37 | Orofaciodigital syndrome vi | Enrichment | KIF7, PDE6D, TMEM216 | 4.42 |
| 38 | Pallister-hall-like syndrome | Enrichment | SCLT1, SMO | 4.41 |
| 39 | Senior-boichis syndrome | Enrichment | DCDC2, TMEM67 | 4.41 |
| 40 | Medulloblastoma | Enrichment | GPR161, PTCH1, SUFU | 4.08 |
| 41 | Orofaciodigital syndrome iii | Enrichment | IFT140, OFD1 | 4.07 |
| 42 | Oligohydramnios | Enrichment | CC2D2A, TMEM67 | 4.07 |
| 43 | Acrocallosal syndrome | Enrichment | GLI3, KIF7 | 3.94 |
| 44 | Nephronophthisis 2 | Enrichment | INVS, TTC21B | 3.94 |
| 45 | Renal-hepatic-pancreatic dysplasia | Enrichment | NEK8, NPHP3 | 3.94 |
| 46 | Microform holoprosencephaly | Enrichment | PTCH1, SUFU, ZIC2 | 3.90 |
| 47 | Weyers acrofacial dysostosis | Enrichment | EVC, EVC2 | 3.67 |
| 48 | Bardet-biedl syndrome 14 | Enrichment | CEP290, TMEM67 | 3.64 |
| 49 | Orofaciodigital syndrome | Enrichment | TMEM107, WDPCP | 3.64 |
| 50 | Polycystic liver disease 1 with or without kidney cysts | Enrichment | PKD1, PKD2 | 3.42 |
| 51 | Polycystic kidney disease 3 with or without polycystic liver disease | Enrichment | PKD1, PKHD1 | 3.42 |
| 52 | Polycystic liver disease 1 | Enrichment | PKD1, PKD2 | 3.42 |
| 53 | Cone dystrophy | Enrichment | BBS5, CFAP410, WDR19 | 3.36 |
| 54 | Polydactyly | Enrichment | CC2D2A, MKS1 | 3.29 |
| 55 | Congenital nervous system abnormality | Enrichment | BBS12, CEP290, TMEM216, TMEM67, ZIC2 | 3.28 |
| 56 | Nervous system disease | Enrichment | BBS12, CEP290, TMEM216, TMEM67, ZIC2 | 3.28 |
| 57 | Basal cell nevus syndrome 1 | Enrichment | PTCH1, SUFU | 3.24 |
| 58 | Renal dysplasia, cystic | Enrichment | CEP290, PKD1 | 3.24 |
| 59 | Primary bone dysplasia | Enrichment | DYNC2H1, INPP5E | 3.20 |
| 60 | Osteochondrodysplasia | Enrichment | DYNC2H1, INPP5E | 3.11 |
| 61 | Ciliopathy | Enrichment | CC2D2A, CEP83 | 3.11 |
| 62 | Polycystic kidney disease 1 with or without polycystic liver disease | Enrichment | PKD1, PKD2 | 3.10 |
| 63 | Arima syndrome | Enrichment | CEP290, TMEM216 | 3.10 |
| 64 | Polycystic kidney disease 1 | Enrichment | PKD1, PKD2 | 3.10 |
| 65 | Stargardt disease 1 | Enrichment | CRX, LCA5, PCARE | 3.07 |
| 66 | Connective tissue disease | Enrichment | NEK1, TTC21B, WDR19 | 2.99 |
| 67 | Leber congenital amaurosis 1 | Enrichment | CRX, LCA5 | 2.97 |
| 68 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | CC2D2A, INPP5E | 2.96 |
| 69 | Clubfoot | Enrichment | CC2D2A, INPP5E | 2.96 |
| 70 | Cone-rod dystrophy 6 | Enrichment | ARL3, MKKS | 2.89 |
| 71 | Epilepsy, myoclonic juvenile | Enrichment | CILK1, EFHC1 | 2.69 |
| 72 | Meningioma | Enrichment | SMO, SUFU | 2.61 |
| 73 | Chronic kidney disease | Enrichment | MKS1, PKD2 | 2.54 |
| 74 | Retinitis pigmentosa 23 | Enrichment | OFD1 | 2.42 |
| 75 | Simpson-golabi-behmel syndrome, type 2 | Enrichment | OFD1 | 2.42 |
| 76 | Mckusick-kaufman syndrome | Enrichment | MKKS | 2.42 |
| 77 | Meckel syndrome, type 3 | Enrichment | TMEM67 | 2.42 |
| 78 | Bardet-biedl syndrome 12 | Enrichment | BBS12 | 2.42 |
| 79 | Bardet-biedl syndrome 17 | Enrichment | LZTFL1 | 2.42 |
| 80 | Senior-loken syndrome 8 | Enrichment | WDR19 | 2.42 |
| 81 | Joubert syndrome 6 | Enrichment | TMEM67 | 2.42 |
| 82 | Cranioectodermal dysplasia 4 | Enrichment | WDR19 | 2.42 |
| 83 | Rhyns syndrome | Enrichment | TMEM67 | 2.42 |
| 84 | Retinitis pigmentosa 93 | Enrichment | CC2D2A | 2.42 |
| 85 | Orofaciodigital syndrome xviii | Enrichment | IFT57 | 2.42 |
| 86 | Joubert syndrome 35 | Enrichment | ARL3 | 2.42 |
| 87 | Short-rib thoracic dysplasia 18 with polydactyly | Enrichment | IFT43 | 2.42 |
| 88 | Epilepsy, juvenile myoclonic 10 | Enrichment | CILK1 | 2.42 |
| 89 | Biliary, renal, neurologic, and skeletal syndrome | Enrichment | IFT56 | 2.42 |
| 90 | Joubert syndrome 9 | Enrichment | CC2D2A | 2.42 |
| 91 | Bardet-biedl syndrome 8 | Enrichment | TTC8 | 2.42 |
| 92 | Hepatorenocardiac degenerative fibrosis | Enrichment | TULP3 | 2.42 |
| 93 | Coach syndrome 2 | Enrichment | CC2D2A | 2.42 |
| 94 | Morbid obesity and spermatogenic failure | Enrichment | CEP19 | 2.42 |
| 95 | Spermatogenic failure 72 | Enrichment | WDR19 | 2.42 |
| 96 | Bardet-biedl syndrome 6 | Enrichment | MKKS | 2.42 |
| 97 | Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome | Enrichment | INPP5E | 2.42 |
| 98 | Short-rib thoracic dysplasia 5 with or without polydactyly | Enrichment | WDR19 | 2.42 |
| 99 | Endocrine-cerebroosteodysplasia | Enrichment | CILK1 | 2.42 |
| 100 | Cranioectodermal dysplasia 3 | Enrichment | IFT43 | 2.42 |
| 101 | Nephronophthisis 13 | Enrichment | WDR19 | 2.42 |
| 102 | Bardet-biedl syndrome 7 | Enrichment | BBS7 | 2.42 |
| 103 | Nephronophthisis 11 | Enrichment | TMEM67 | 2.42 |
| 104 | Peritonitis | Enrichment | TMEM67 | 2.42 |
| 105 | Cranioectodermal dysplasia 6 | Enrichment | CILK1 | 2.42 |
| 106 | Retinitis pigmentosa 51 | Enrichment | TTC8 | 2.42 |
| 107 | Joubert syndrome 13 | Enrichment | TCTN1 | 2.42 |
| 108 | Retinitis pigmentosa 81 | Enrichment | IFT43 | 2.42 |
| 109 | Short-rib thoracic dysplasia 8 with or without polydactyly | Enrichment | DYNC2I1 | 2.42 |
| 110 | Senior-loken syndrome 9 | Enrichment | TRAF3IP1 | 2.42 |
| 111 | Short-rib thoracic dysplasia 16 with or without polydactyly | Enrichment | IFT52 | 2.42 |
| 112 | Short-rib thoracic dysplasia 19 with or without polydactyly | Enrichment | IFT81 | 2.42 |
| 113 | Joubert syndrome 40 | Enrichment | IFT74 | 2.42 |
| 114 | Retinitis pigmentosa 83 | Enrichment | ARL3 | 2.42 |
| 115 | Intellectual disability-hyperkinetic movement-truncal ataxia syndrome | Enrichment | TRAPPC11 | 2.42 |
| 116 | Spermatogenic failure 58 | Enrichment | IFT74 | 2.42 |
| 117 | Nephronophthisis 18 | Enrichment | CEP83 | 2.42 |
| 118 | Lung disease | Enrichment | DYNC2H1 | 2.42 |
| 119 | Pancreatitis | Enrichment | TMEM67 | 2.42 |
| 120 | Syndromic inherited retinal disorder | Enrichment | MKKS | 2.42 |
| 121 | Kidney disease | Enrichment | CEP290, PKD1 | 2.41 |
| 122 | Septopreoptic holoprosencephaly | Enrichment | PTCH1, ZIC2 | 2.41 |
| 123 | Midline interhemispheric variant of holoprosencephaly | Enrichment | PTCH1, ZIC2 | 2.41 |
| 124 | Creatine phosphokinase, elevated serum | Enrichment | PKD1, TRIM32 | 2.36 |
| 125 | Hypertension | Enrichment | PKD1, PKD2 | 2.36 |
| 126 | Isolated elevated serum creatine phosphokinase levels | Enrichment | PKD1, TRIM32 | 2.36 |
| 127 | Lobar holoprosencephaly | Enrichment | PTCH1, ZIC2 | 2.36 |
| 128 | Spastic ataxia | Enrichment | CEP290, MKS1, TMEM67 | 2.35 |
| 129 | Polycystic liver disease | Enrichment | PKD2, PKHD1 | 2.30 |
| 130 | Autosomal dominant polycystic liver disease | Enrichment | PKD2, PKHD1 | 2.30 |
| 131 | Alobar holoprosencephaly | Enrichment | PTCH1, ZIC2 | 2.30 |
| 132 | Semilobar holoprosencephaly | Enrichment | PTCH1, ZIC2 | 2.25 |
| 133 | Pallister-hall syndrome | Enrichment | GLI3 | 2.20 |
| 134 | Greig cephalopolysyndactyly syndrome | Enrichment | GLI3 | 2.20 |
| 135 | Pneumothorax, primary spontaneous | Enrichment | FLCN | 2.20 |
| 136 | Congenital heart defects, hamartomas of tongue, and polysyndactyly | Enrichment | WDPCP | 2.20 |
| 137 | Bardet-biedl syndrome 3 | Enrichment | ARL6 | 2.20 |
| 138 | Intellectual developmental disorder, x-linked 99 | Enrichment | USP9X | 2.20 |
| 139 | Curry-jones syndrome | Enrichment | SMO | 2.20 |
| 140 | Epilepsy, juvenile absence 1 | Enrichment | EFHC1 | 2.20 |
| 141 | Joubert syndrome 2 | Enrichment | TMEM216 | 2.20 |
| 142 | Schilbach-rott syndrome | Enrichment | PTCH1 | 2.20 |
| 143 | Polydactyly, preaxial iv | Enrichment | GLI3 | 2.20 |
| 144 | Senior-loken syndrome 5 | Enrichment | IQCB1 | 2.20 |
| 145 | Hydrolethalus syndrome 2 | Enrichment | KIF7 | 2.20 |
| 146 | Renal-hepatic-pancreatic dysplasia 2 | Enrichment | NEK8 | 2.20 |
| 147 | Leber congenital amaurosis 7 | Enrichment | CRX | 2.20 |
| 148 | Retinitis pigmentosa 55 | Enrichment | ARL6 | 2.20 |
| 149 | Bardet-biedl syndrome 4 | Enrichment | BBS4 | 2.20 |
| 150 | Joubert syndrome 8 | Enrichment | ARL13B | 2.20 |
| 151 | Nephronophthisis 9 | Enrichment | NEK8 | 2.20 |
| 152 | Retinitis pigmentosa 98 | Enrichment | TMEM216 | 2.20 |
| 153 | Joubert syndrome 22 | Enrichment | PDE6D | 2.20 |
| 154 | Joubert syndrome 32 | Enrichment | SUFU | 2.20 |
| 155 | Birt-hogg-dube syndrome | Enrichment | FLCN | 2.20 |
| 156 | Retinitis pigmentosa 62 | Enrichment | MAK | 2.20 |
| 157 | Al-gazali-bakalinova syndrome | Enrichment | KIF7 | 2.20 |
| 158 | Intellectual developmental disorder, x-linked 99, syndromic, female-restricted | Enrichment | USP9X | 2.20 |
| 159 | Lowe oculocerebrorenal syndrome | Enrichment | OCRL | 2.20 |
| 160 | Bardet-biedl syndrome 15 | Enrichment | WDPCP | 2.20 |
| 161 | Meckel syndrome, type 2 | Enrichment | TMEM216 | 2.20 |
| 162 | Joubert syndrome 15 | Enrichment | CEP41 | 2.20 |
| 163 | Retinitis pigmentosa 54 | Enrichment | PCARE | 2.20 |
| 164 | Bardet-biedl syndrome 18 | Enrichment | BBIP1 | 2.20 |
| 165 | Nephronophthisis 15 | Enrichment | CEP164 | 2.20 |
| 166 | Retinitis pigmentosa 45 | Enrichment | CNGB1 | 2.20 |
| 167 | Retinitis pigmentosa 74 | Enrichment | BBS2 | 2.20 |
| 168 | Amyotrophic lateral sclerosis 24 | Enrichment | NEK1 | 2.20 |
| 169 | Polycystic kidney disease 8 | Enrichment | NEK8 | 2.20 |
| 170 | Juvenile absence epilepsy | Enrichment | EFHC1 | 2.20 |
| 171 | Multiple epiphyseal dysplasia, al-gazali type | Enrichment | KIF7 | 2.20 |
| 172 | Bardet-biedl syndrome 2 | Enrichment | BBS2 | 2.20 |
| 173 | Non-syndromic non-specific multisutural craniosynostosis | Enrichment | FUZ | 2.20 |
| 174 | Female-restricted syndromic x-linked intellectual disability 99 | Enrichment | USP9X | 2.20 |
| 175 | Turner syndrome | Enrichment | PTCH1 | 2.20 |
| 176 | Renovascular hypertension | Enrichment | PKD1 | 2.20 |
| 177 | Familial spontaneous pneumothorax | Enrichment | FLCN | 2.20 |
| 178 | Monosomy 9q22.3 | Enrichment | PTCH1 | 2.20 |
| 179 | Spondyloepiphyseal dysplasia tarda, x-linked | Enrichment | OFD1 | 2.12 |
| 180 | Orofaciodigital syndrome i | Enrichment | OFD1 | 2.12 |
| 181 | Nephronophthisis 4 | Enrichment | BBS9 | 2.12 |
| 182 | Bardet-biedl syndrome 10 | Enrichment | BBS10 | 2.12 |
| 183 | Short-rib thoracic dysplasia 17 with or without polydactyly | Enrichment | DYNLT2B | 2.12 |
| 184 | Leber congenital amaurosis 6 | Enrichment | MKS1 | 2.12 |
| 185 | Cranioectodermal dysplasia 2 | Enrichment | WDR35 | 2.12 |
| 186 | Carpenter syndrome 1 | Enrichment | RAB23 | 2.12 |
| 187 | Polycystic kidney disease 9 | Enrichment | IFT140 | 2.12 |
| 188 | Joubert syndrome 30 | Enrichment | ARMC9 | 2.12 |
| 189 | Sitosterolemia 2 | Enrichment | DYNC2LI1 | 2.12 |
| 190 | Cranioectodermal dysplasia 5 | Enrichment | IFT140 | 2.12 |
| 191 | Spondyloepiphyseal dysplasia tarda | Enrichment | OFD1 | 2.12 |
| 192 | Bardet-biedl syndrome 13 | Enrichment | MKS1 | 2.12 |
| 193 | Short-rib thoracic dysplasia 15 with polydactyly | Enrichment | DYNC2LI1 | 2.12 |
| 194 | Bardet-biedl syndrome 9 | Enrichment | BBS9 | 2.12 |
| 195 | Muscular dystrophy, limb-girdle, autosomal recessive 18 | Enrichment | TRAPPC11 | 2.12 |
| 196 | Short-rib thoracic dysplasia 7 with or without polydactyly | Enrichment | WDR35 | 2.12 |
| 197 | Joubert syndrome 28 | Enrichment | MKS1 | 2.12 |
| 198 | Intellectual developmental disorder, autosomal recessive 77 | Enrichment | CEP104 | 2.12 |
| 199 | Short femur | Enrichment | INPP5E | 2.12 |
| 200 | Cerebellar malformation | Enrichment | TMEM67 | 2.12 |
| 201 | Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene | Enrichment | IFT140 | 2.12 |
| 202 | Inherited cancer-predisposing syndrome | Enrichment | FLCN, PKD1, PTCH1, SUFU | 2.02 |
| 203 | Simpson-golabi-behmel syndrome, type 1 | Enrichment | OFD1 | 1.94 |
| 204 | Caroli disease, isolated | Enrichment | IFT56 | 1.94 |
| 205 | Meckel syndrome, type 6 | Enrichment | CC2D2A | 1.94 |
| 206 | Joubert syndrome 25 | Enrichment | CEP104 | 1.94 |
| 207 | Sitosterolemia 1 | Enrichment | DYNC2LI1 | 1.94 |
| 208 | Bardet-biedl syndrome 19 | Enrichment | IFT27 | 1.94 |
| 209 | Short-rib thoracic dysplasia 11 with or without polydactyly | Enrichment | DYNC2I2 | 1.94 |
| 210 | Caroli disease | Enrichment | IFT56 | 1.94 |
| 211 | Sitosterolemia | Enrichment | DYNC2LI1 | 1.94 |
| 212 | Interstitial lung disease | Enrichment | INPP5E | 1.94 |
| 213 | Polydactyly, postaxial, type a7 | Enrichment | IQCE | 1.94 |
| 214 | Retinitis pigmentosa 80 | Enrichment | IFT140 | 1.94 |
| 215 | Respiratory failure | Enrichment | INPP5E | 1.94 |
| 216 | Birt-hogg-dube syndrome 1 | Enrichment | FLCN | 1.90 |
| 217 | Chylomicron retention disease | Enrichment | DCDC2 | 1.90 |
| 218 | Orofaciodigital syndrome ii | Enrichment | NEK1 | 1.90 |
| 219 | Muscular dystrophy, limb-girdle, autosomal recessive 8 | Enrichment | TRIM32 | 1.90 |
| 220 | Dent disease 2 | Enrichment | OCRL | 1.90 |
| 221 | Short-rib thoracic dysplasia 2 with or without polydactyly | Enrichment | IFT80 | 1.90 |
| 222 | Holoprosencephaly 5 | Enrichment | ZIC2 | 1.90 |
| 223 | Nephronophthisis 12 | Enrichment | TTC21B | 1.90 |
| 224 | Deafness, autosomal recessive 66 | Enrichment | DCDC2 | 1.90 |
| 225 | Bardet-biedl syndrome 5 | Enrichment | BBS5 | 1.90 |
| 226 | Bardet-biedl syndrome 11 | Enrichment | TRIM32 | 1.90 |
| 227 | Heterotaxy, visceral, 8, autosomal | Enrichment | PKD1L1 | 1.90 |
| 228 | Short-rib thoracic dysplasia 4 with or without polydactyly | Enrichment | TTC21B | 1.90 |
| 229 | Polycystic liver disease 2 with or without kidney cysts | Enrichment | LCA5 | 1.90 |
| 230 | Spondylometaphyseal dysplasia, axial | Enrichment | CFAP410 | 1.90 |
| 231 | Nephronophthisis 19 | Enrichment | DCDC2 | 1.90 |
| 232 | Orofaciodigital syndrome xvi | Enrichment | TMEM107 | 1.90 |
| 233 | Developmental and epileptic encephalopathy 88 | Enrichment | WDPCP | 1.90 |
| 234 | Retinitis pigmentosa 49 | Enrichment | CNGA1 | 1.90 |
| 235 | Retinal dystrophy with or without macular staphyloma | Enrichment | CFAP410 | 1.90 |
| 236 | Leber congenital amaurosis 5 | Enrichment | LCA5 | 1.90 |
| 237 | Tibial hemimelia | Enrichment | GLI3 | 1.90 |
| 238 | Autosomal recessive limb-girdle muscular dystrophy type 2h | Enrichment | TRIM32 | 1.90 |
| 239 | Senior-loken syndrome 7 | Enrichment | SDCCAG8 | 1.90 |
| 240 | Synpolydactyly | Enrichment | GLI3 | 1.90 |
| 241 | Congenital fibrosarcoma | Enrichment | SUFU | 1.90 |
| 242 | Bardet-biedl syndrome 16 | Enrichment | SDCCAG8 | 1.90 |
| 243 | Sclerosing cholangitis, neonatal | Enrichment | DCDC2 | 1.90 |
| 244 | Polycystic kidney disease 3 | Enrichment | PKD1 | 1.90 |
| 245 | Basal cell nevus syndrome 2 | Enrichment | SUFU | 1.90 |
| 246 | Postaxial polydactyly type b | Enrichment | GLI3 | 1.90 |
| 247 | Joubert syndrome 29 | Enrichment | TMEM107 | 1.90 |
| 248 | Isolated neonatal sclerosing cholangitis | Enrichment | DCDC2 | 1.90 |
| 249 | Hirschsprung disease 1 | Enrichment | GLI3, SMO | 1.85 |
| 250 | Achalasia-addisonianism-alacrima syndrome | Enrichment | TRAPPC11 | 1.82 |
| 251 | Astigmatism | Enrichment | SCLT1 | 1.82 |
| 252 | Short-rib thoracic dysplasia 10 with or without polydactyly | Enrichment | IFT172 | 1.82 |
| 253 | Retinitis pigmentosa 71 | Enrichment | IFT172 | 1.82 |
| 254 | Bardet-biedl syndrome 20 | Enrichment | IFT172 | 1.82 |
| 255 | Syndactyly | Enrichment | IQCE | 1.82 |
| 256 | Newborn respiratory distress syndrome | Enrichment | DYNC2H1 | 1.82 |
| 257 | Anencephaly | Enrichment | CC2D2A | 1.82 |
| 258 | Homocystinuria due to cystathionine beta-synthase deficiency | Enrichment | PKHD1 | 1.73 |
| 259 | Aarskog-scott syndrome | Enrichment | GLI3 | 1.73 |
| 260 | Dyslexia 2 | Enrichment | DCDC2 | 1.73 |
| 261 | Polycystic kidney disease, infantile severe, with tuberous sclerosis | Enrichment | PKD1 | 1.73 |
| 262 | Meckel syndrome, type 7 | Enrichment | NPHP3 | 1.73 |
| 263 | Senior-loken syndrome 6 | Enrichment | CEP290 | 1.73 |
| 264 | Nephronophthisis 3 | Enrichment | NPHP3 | 1.73 |
| 265 | Joubert syndrome 5 | Enrichment | CEP290 | 1.73 |
| 266 | Holoprosencephaly 7 | Enrichment | PTCH1 | 1.73 |
| 267 | Tuberous sclerosis 2 | Enrichment | PKD1 | 1.73 |
| 268 | Polycystic kidney disease 2 with or without polycystic liver disease | Enrichment | PKD2 | 1.73 |
| 269 | Dent disease | Enrichment | OCRL | 1.73 |
| 270 | Umbilical hernia | Enrichment | GLI3 | 1.73 |
| 271 | Polycystic kidney disease 4 | Enrichment | PKHD1 | 1.73 |
| 272 | Hydrolethalus syndrome | Enrichment | KIF7 | 1.73 |
| 273 | Polycystic kidney disease 2 | Enrichment | PKD2 | 1.73 |
| 274 | Potocki-lupski syndrome | Enrichment | FLCN | 1.73 |
| 275 | Bardet-biedl syndrome 21 | Enrichment | CFAP418 | 1.73 |
| 276 | Chromophobe renal cell carcinoma | Enrichment | FLCN | 1.73 |
| 277 | End stage renal disease | Enrichment | PKD1 | 1.73 |
| 278 | Desmoplastic/nodular medulloblastoma | Enrichment | SUFU | 1.73 |
| 279 | Cog7-congenital disorder of glycosylation | Enrichment | CEP290 | 1.73 |
| 280 | Occipital encephalocele | Enrichment | CEP290 | 1.73 |
| 281 | Hyperpigmentation of the skin | Enrichment | USP9X | 1.73 |
| 282 | Late-onset nephronophthisis | Enrichment | NPHP3 | 1.73 |
| 283 | Muscular dystrophy, limb-girdle, autosomal recessive 23 | Enrichment | TRAPPC11 | 1.72 |
| 284 | Macular degeneration | Enrichment | BBS10 | 1.72 |
| 285 | Joubert syndrome with jeune asphyxiating thoracic dystrophy | Enrichment | IFT140 | 1.72 |
| 286 | Farsightedness | Enrichment | SCLT1 | 1.72 |
| 287 | Eye disease | Enrichment | ARL6, BBS9 | 1.69 |
| 288 | Patent ductus arteriosus | Enrichment | INPP5E | 1.64 |
| 289 | Retinitis pigmentosa 91 | Enrichment | CRX | 1.60 |
| 290 | Polydactyly, preaxial ii | Enrichment | PTCH1 | 1.60 |
| 291 | Renal-hepatic-pancreatic dysplasia 1 | Enrichment | NPHP3 | 1.60 |
| 292 | Sacral defect with anterior meningocele | Enrichment | FUZ | 1.60 |
| 293 | Meckel syndrome, type 4 | Enrichment | CEP290 | 1.60 |
| 294 | Pregnancy loss, recurrent 3 | Enrichment | PKHD1 | 1.60 |
| 295 | Cone-rod dystrophy 16 | Enrichment | CFAP418 | 1.60 |
| 296 | Meckel syndrome 13 | Enrichment | TMEM107 | 1.60 |
| 297 | Tuberous sclerosis | Enrichment | PKD1 | 1.60 |
| 298 | Pilocytic astrocytoma | Enrichment | FLCN | 1.60 |
| 299 | Oculomotor apraxia | Enrichment | SUFU | 1.60 |
| 300 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | KIF7 | 1.60 |
| 301 | Brachydactyly | Enrichment | IQCE | 1.58 |
| 302 | Retinal degeneration | Enrichment | IQCE | 1.58 |
| 303 | Spastic paraplegia 4, autosomal dominant | Enrichment | OFD1 | 1.52 |
| 304 | Spermatogenic failure 5 | Enrichment | IFT74 | 1.52 |
| 305 | Pseudovaginal perineoscrotal hypospadias | Enrichment | BBIP1 | 1.51 |
| 306 | Leber congenital amaurosis 10 | Enrichment | CEP290 | 1.51 |
| 307 | Holoprosencephaly | Enrichment | ZIC2 | 1.51 |
| 308 | Night blindness | Enrichment | CEP290 | 1.51 |
| 309 | Hemangioma | Enrichment | PKD1 | 1.51 |
| 310 | Optic atrophy plus syndrome | Enrichment | BBS7, NPHP3 | 1.51 |
| 311 | Limb-girdle muscular dystrophy | Enrichment | TRAPPC11 | 1.47 |
| 312 | Holoprosencephaly 1 | Enrichment | ZIC2 | 1.43 |
| 313 | Basal cell carcinoma 1 | Enrichment | PTCH1 | 1.43 |
| 314 | Childhood absence epilepsy | Enrichment | EFHC1 | 1.43 |
| 315 | Cat eye syndrome | Enrichment | TMEM67 | 1.42 |
| 316 | Polymicrogyria | Enrichment | OFD1 | 1.42 |
| 317 | Leukoencephalopathy, brain calcifications, and cysts | Enrichment | TMEM107 | 1.37 |
| 318 | Motor neuron disease | Enrichment | NEK1 | 1.37 |
| 319 | Congenital hydrocephalus | Enrichment | PTCH1 | 1.37 |
| 320 | Overgrowth syndrome | Enrichment | PTCH1 | 1.37 |
| 321 | Hereditary clear cell renal cell carcinoma | Enrichment | FLCN | 1.37 |
| 322 | Muscular dystrophy, limb-girdle, autosomal recessive 2 | Enrichment | TRAPPC11 | 1.35 |
| 323 | Microphthalmia/coloboma 12 | Enrichment | TMEM67 | 1.31 |
| 324 | Immunodeficiency 47 | Enrichment | CEP290 | 1.31 |
| 325 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | CFAP410, NEK1 | 1.29 |
| 326 | Osteoporosis | Enrichment | OFD1 | 1.28 |
| 327 | Nephrotic syndrome, type 1 | Enrichment | TTC21B | 1.26 |
| 328 | Coloboma of macula | Enrichment | TMEM67 | 1.25 |
| 329 | Hydrocephalus | Enrichment | IFT56 | 1.25 |
| 330 | Hydrocephalus, congenital, 1 | Enrichment | OFD1 | 1.22 |
| 331 | Cleft palate, isolated | Enrichment | INPP5E | 1.20 |
| 332 | Dandy-walker syndrome | Enrichment | ARMC9 | 1.20 |
| 333 | Meningioma, familial | Enrichment | SUFU | 1.18 |
| 334 | Specific learning disability | Enrichment | BBIP1 | 1.18 |
| 335 | Heart, malformation of | Enrichment | DYNC2H1 | 1.17 |
| 336 | Autosomal recessive limb-girdle muscular dystrophy | Enrichment | TRAPPC11 | 1.15 |
| 337 | Diaphragmatic hernia, congenital | Enrichment | GLI3 | 1.11 |
| 338 | Neural tube defects | Enrichment | FUZ | 1.11 |
| 339 | Attention deficit-hyperactivity disorder | Enrichment | CDK20 | 1.09 |
| 340 | Hypogonadotropic hypogonadism 7 with or without anosmia | Enrichment | BBIP1 | 1.07 |
| 341 | Pituitary stalk interruption syndrome | Enrichment | GPR161 | 1.07 |
| 342 | Isolated macular dystrophy | Enrichment | MAK | 1.07 |
| 343 | Muscular dystrophy | Enrichment | TRAPPC11 | 1.05 |
| 344 | Renal cell carcinoma, nonpapillary | Enrichment | FLCN | 1.05 |
| 345 | Rhabdomyosarcoma | Enrichment | PTCH1 | 1.02 |
| 346 | Colorectal cancer | Enrichment | FLCN, PKHD1 | 0.99 |
| 347 | Severe covid-19 | Enrichment | CC2D2A | 0.98 |
| 348 | Macs syndrome | Enrichment | PTCH1 | 0.93 |
| 349 | Craniosynostosis | Enrichment | GLI3 | 0.93 |
| 350 | Focal segmental glomerulosclerosis | Enrichment | SDCCAG8 | 0.93 |
| 351 | Dystonia | Enrichment | CEP104 | 0.90 |
| 352 | Visceral heterotaxy | Enrichment | PKD1L1 | 0.89 |
| 353 | Microphthalmia | Enrichment | PTCH1 | 0.89 |
| 354 | Ovarian cancer | Enrichment | FLCN, PTCH1 | 0.88 |
| 355 | Strabismus | Enrichment | KIF7 | 0.81 |
| 356 | Visceral heterotaxy 5 | Enrichment | PKD1L1 | 0.75 |
| 357 | Usher syndrome | Enrichment | BBS1 | 0.73 |
| 358 | Autosomal recessive non-syndromic intellectual disability | Enrichment | CEP104 | 0.70 |
| 359 | Non-syndromic x-linked intellectual disability | Enrichment | USP9X | 0.69 |
| 360 | Epilepsy | Enrichment | TTC21B | 0.65 |
| 361 | Myopathy | Enrichment | TRIM32 | 0.65 |
| 362 | Nonsyndromic hearing loss | Enrichment | DCDC2 | 0.63 |
| 363 | Nephrotic syndrome | Enrichment | TTC21B | 0.62 |
| 364 | Primary ciliary dyskinesia | Enrichment | OFD1 | 0.60 |
| 365 | Body mass index quantitative trait locus 11 | Enrichment | BBIP1 | 0.57 |
| 366 | Hereditary breast ovarian cancer syndrome | Enrichment | PTCH1 | 0.53 |
| 367 | Autism spectrum disorder | Enrichment | CEP104 | 0.46 |
| 368 | Microcephaly | Enrichment | CC2D2A | 0.42 |
| 369 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | DCDC2 | 0.37 |